Nova Patents
AT323183T

Nucleotide sequences derived from the genomes of the retroviruses HIV-1, HIV-2 and SIV, and their application to the amplification of pol sequences in these viral genomes and to the in vitro diagnosis of infections resulting from these viruses

Abstract

oligonucleotide characterized in that its sequence consists of: i) a specific sequence of the gag gene or the gene pol, and suitable is, at a temperature of 60 ° C ± 1 ° C to the Genome of the HIV-1 Bru, HIV-1 time, HIV-1 Eli, HIV-2 Rod or SIV Mac hybridize to, or ii) a complementary sequence a sequence as defined in i).

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

72 members in 13 offices

This recordMember, by publication datePriority claim3 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
8907354FranceA
8912371FranceA

Members72

Family members, oldest first
DocumentOfficeKind
CA2062829A1CanadaA1
FR2647809A1FranceA1
CA2585164A1CanadaA1
CA2685262A1CanadaA1
WO9015066A2World Intellectual Property Organization (WIPO)A2
EP0403333A2European Patent Office (EPO)A2
FR2652091A1FranceA1
WO9015066A3World Intellectual Property Organization (WIPO)A3
FR2647809B1FranceB1
EP0403333A3European Patent Office (EPO)A3
JPH04507043AJapanA
FR2652091B1FranceB1
EP0806484A2European Patent Office (EPO)A2
US5688637AUnited States of AmericaA
SG47868A1SingaporeA1
US5786177AUnited States of AmericaA
EP0403333B1European Patent Office (EPO)B1
AT185379TAustriaT
ATE185379T1AustriaT1
DE69033311D1GermanyD1
ES2139567T3SpainT3
DE69033311T2GermanyT2
DK0403333T3DenmarkT3
JP2000093187AJapanA
GR3032261T3GreeceT3
EP0806484A3European Patent Office (EPO)A3
US6194142B1United States of AmericaB1
JP3428012B2JapanB2
US2005037340A1United States of AmericaA1
US2006035260A1United States of AmericaA1
US7022814B1United States of AmericaB1
EP1642987A2European Patent Office (EPO)A2
EP0806484B1European Patent Office (EPO)B1
AT323183TThis recordAustriaT
ATE323183T1AustriaT1
DE69034220D1GermanyD1
US7078516B1United States of AmericaB1
DK0806484T3DenmarkT3
EP1642987A3European Patent Office (EPO)A3
EP1715064A1European Patent Office (EPO)A1
ES2262166T3SpainT3
DE69034220T2GermanyT2
HK1092839A1Hong Kong, ChinaA1
DE05014676T1GermanyT1
EP1715064A8European Patent Office (EPO)A8
ES2275451T1SpainT1
HK1097574A1Hong Kong, ChinaA1
CA2062829CCanadaC
EP1642987B1European Patent Office (EPO)B1
AT404699TAustriaT
ATE404699T1AustriaT1
DE69034260D1GermanyD1
DK1642987T3DenmarkT3
EP2011888A1European Patent Office (EPO)A1
ES2275451T3SpainT3
EP1715064B1European Patent Office (EPO)B1
AT423856TAustriaT
ATE423856T1AustriaT1
ES2315215T1SpainT1
DE69034265D1GermanyD1
DE07025195T1GermanyT1
ES2321326T3SpainT3
DK1715064T3DenmarkT3
HK1125136A1Hong Kong, ChinaA1
CA2585164CCanadaC
EP2011888B1European Patent Office (EPO)B1
AT466111TAustriaT
ATE466111T1AustriaT1
DE69034267D1GermanyD1
US7759477B2United States of AmericaB2
DK2011888T3DenmarkT3
US7777020B2United States of AmericaB2